Overdiagnosis in Primary Care: Framing the Problem and Finding Solutions
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Evidence for Overuse of Medical Services Around the World
Series Right care 1 Evidence for overuse of medical services around the world Shannon Brownlee, Kalipso Chalkidou, Jenny Doust, Adam G Elshaug, Paul Glasziou, Iona Heath*, Somil Nagpal, Vikas Saini, Divya Srivastava, Kelsey Chalmers, Deborah Korenstein Lancet 2017; 390: 156–68 Overuse, which is defined as the provision of medical services that are more likely to cause harm than good, is a Published Online pervasive problem. Direct measurement of overuse through documentation of delivery of inappropriate services is January 8, 2017 challenging given the difficulty of defining appropriate care for patients with individual preferences and needs; overuse http://dx.doi.org/10.1016/ can also be measured indirectly through examination of unwarranted geographical variations in prevalence of S0140-6736(16)32585-5 procedures and care intensity. Despite the challenges, the high prevalence of overuse is well documented in high-income This is the first in a Series of four papers about right care countries across a wide range of services and is increasingly recognised in low-income countries. Overuse of unneeded See Comment pages 101, 102, services can harm patients physically and psychologically, and can harm health systems by wasting resources and and 105 deflecting investments in both public health and social spending, which is known to contribute to health. Although Lown Institute, Brookline, MA, harms from overuse have not been well quantified and trends have not been well described, overuse is likely to be USA (S Brownlee MSc, increasing worldwide. -
Overtreatment and Informed Consent: a Fraud-Based Solution to Unwanted and Unnecessary Care
OVERTREATMENT AND INFORMED CONSENT: A FRAUD-BASED SOLUTION TO UNWANTED AND UNNECESSARY CARE ISAAC D. BUCKt ABSTRACT According to multiple accounts, the administrationof American health care results in as much as $800 billion in wasted spending due largely to the provision of overly expensive, inefficient, and unnecessary services. Beyond inflictingfiscal pain on the nation'spocketbook, this waste has no clinical benefit-and often results in unnecessary hospital stays, cascading follow-up procedures, and time-wasting inconvenience for American patients. But aside from the mere annoyance of unnecessary care, the administrationof overtreatment-thatis, unnec- essary care in and of itself-causes harm to the patient. Excessive care is deficient care. Un- necessary care risks potential medical error and infection, and often subjects the patient to excessive recovery and rehabilitation. In addition to the fiscal reasons, it is not a stretch to observe that it makes little or no sense for American patients to desire unnecessary care. But yet, as a general matter, today's modern and patient-protective legal and bioethical framework governing American health carepurportedly forcefully protects patients from un- desirable care by requiring their informed consent before any procedure or service. The im- portanceof informed consent is well settled, and it is recognized as a sacred value in American health care. In law and bioethics, this value is so sanctified that in cases where providers fail to achieve informed consent, legal recourse is availablefor the wronged patient. The prevalence of overtreatment, when juxtaposed with the sanctity of informed consent, is a perplexing legal and policy-based problem. Specifically, this disconnect that results- between the robust protection of informed consent and patient autonomy on one hand, and the naggingproblem of undesirableand harmful overtreatment on the other-calls out for a reasoned legal resolution. -
Preventing Overdiagnosis: How to Stop Harming the Healthy
MEDICALISATION bmj.com � BMJ blog: Elizabeth Loder on tackling unnecessary treatment in the US: This time “it feels diff erent” � Des Spence: The psychiatric oligarchs who medicalise normality (BMJ 2012;344:e3135) � Research: Overdiagnosis in publicly organised mammography screening programmes (BMJ 2009;339:b2587) Preventing overdiagnosis: how to stop harming the healthy Evidence is mounting that medicine is harming healthy people through ever earlier detection and ever wider definition of disease. With the announcement of an international conference to improve understanding of the problem of overdiagnosis, Ray Moynihan , Jenny Doust , and David Henry examine its causes and explore solutions edicine’s much hailed ability to help the sick is fast being challenged by its propensity to harm the healthy. A burgeon- ing scientifi c literature is fuel- M ling public concerns that too many people are being overdosed, 1 overtreated, 2 and overdiag- nosed. 3 Screening programmes are detecting early cancers that will never cause symptoms or death, 4 sensitive diagnostic technologies iden- tify “abnormalities” so tiny they will remain benign, 5 while widening disease defi nitions mean people at ever lower risks receive permanent medical labels and lifelong treatments that will fail to benefit many of them. 3 6 With estimates that more than $200bn (£128bn; €160bn) may be wasted on unnecessary treatment every year in the United States,7 the cumulative burden from overdiagnosis poses a signifi cant threat to human health. Narrowly defined , overdiagnosis occurs when people without symptoms are diagnosed with a disease that ultimately will not cause them to experience symptoms or early death.3 More broadly defi ned, overdiagnosis refers to the related problems of overmedicalisation and subsequent overtreatment, diagnosis creep, shift ing thresholds, and disease mongering, all processes helping to reclassify healthy people with mild problems or at low risk as sick. -
UNNECESSARY CARE Is Profit Driven Healthcare to Blame?
OVERTREATMENT bmj.com News: Experts consider how to tackle overtreatment in US healthcare UNNECESSARY CARE (BMJ 2012;344:e3144) doc2doc Overdiagnosis: do we know when to stop? Discuss at doc2doc Is profit driven bmj.com/multimedia Jeanne Lenzer healthcare to blame? (pictured) investigates the harms of overtreatment A newly launched movement led by prominent doctors is challenging the basic assumption in US healthcare that more is better. Jeanne Lenzer reports t 8 am on her first day as an Medicare recipients alone each year. Overall, Medicaid Services; and Harvey Fineberg, presi- intern, Diane Meier attended the unnecessary interventions are estimated to dent of the Institute of Medicine, which co-hosted resuscitation of an 89 year old man account for 10-30% of spending on healthcare the meeting. with end stage congestive heart in the US, or $250bn-$800bn (£154bn-£490bn; Participants poured out examples of ram- failure. The staff shocked the man’s €190bn-€610bn) annually.2 pant overtreatment, ranging from the overuse heartA repeatedly. They tried four times to place of screening tests and imaging technology to an a central line. They injected pressors directly Signs of change epidemic of questionable surgery (tonsillectomies into his heart, stuck his femoral artery for blood Earlier in the year, Meier, along with more than alone increased by 74% from 1996 to 2006). gases, and performed chest compressions for over 130 prominent doctors from the US, Canada, Rita Redberg, a cardiologist and editor of the an hour before finally pronouncing him dead. and the UK participated in a two day conference Archives of Internal Medicine, told the gathering Two decades later, after witnessing similar pre- on avoiding avoidable care, the first in the US to that many interventions need to be challenged, death rituals countless times, Meier published focus exclusively on overtreatment. -
Choosing Wisely Avoiding Too Much Medicine
Commentary Choosing wisely Avoiding too much medicine Bartosz Hudzik MD PhD Michal Hudzik JD PhD Lech Polonski MD PhD raditionally, the main concern of the medical profes- Sceptics have long warned us about the downside of sion has been to preclude diagnostic errors, with a too much medicine.4,5 A growing body of evidence sug- Tprimary focus on the issues of underdiagnosis and gests that the increasing numbers of medical tests and undertreatment. Therefore, we have witnessed, par- procedures drive up health care costs and, above all, can ticularly in the 20th century, the rapid development of be harmful to patients. Even seemingly safe diagnostic laboratory medicine, imaging techniques, and thera- modalities can be potentially harmful or even fatal if they peutic procedures. The number of available diagnostic lead to a cascade of additional unnecessary testing and tests and treatments has increased dramatically over the invasive procedures with predictable complication rates. past 2 decades.1 In fact, the use of imaging studies has grown faster than that of any other physician service But what to avoid? (Figure 1).1,2 It is estimated that in the United States For many years, we have had the benefit of practice overused or misused diagnostic tests cost approximately guidelines issued by medical societies. However, these $210 billion annually (10% of health care costs).3 recommendations have tended to focus primarily on what procedures to follow, rather than on what tests and Figure 1. Growth in volume of physician services treatments to -
Differentiating Clinical Care from Disease Prevention: a Prerequisite for Practicing Quaternary Prevention
ENSAIO ESSAY 1 Differentiating clinical care from disease prevention: a prerequisite for practicing quaternary prevention Diferenciando o cuidado clínico da prevenção de doença: um pré-requisito para praticar a prevenção quaternária Diferenciando el cuidado clínico de la prevención de la enfermedad: un prerrequisito para la práctica de la prevención cuaternaria Charles Dalcanale Tesser 1,2 Armando Henrique Norman 3 Abstract This article contends that the distinction between clinical care (illness) and 1 Centro de Ciências da Correspondence Saúde, Universidade C. D. Tesser prevention of future disease is essential to the practice of quaternary pre- Federal de Santa Catarina, Departamento de Saúde vention. The authors argue that the ongoing entanglement of clinical care Florianópolis, Brasil. Pública, Centro de Ciências 2 Centro de Estudos Sociais, da Saúde, Universidade and prevention transforms healthy into “sick” people through changes in Universidade de Coimbra, Federal de Santa Catarina. disease classification criteria and/or cut-off points for defining high-risk Coimbra, Portugal. Campus Universitário, states. This diverts health care resources away from those in need of care 3 Department of Florianópolis, SC 88040-900, Anthropology, Durham Brasil. and increases the risk of iatrogenic harm in healthy people. The distinc- University, Durham, England. [email protected] tion in focus is based on: (a) management of uncertainty (more flexible when caring for ill persons); (b) guarantee of benefit (required only in pre- vention); (c) harm tolerance (nil or minimal in prevention). This implies attitudinal differences in the decision-making process: greater skepticism, scientism and resistance towards preventive action. These should be based on high-quality scientific evidence of end-outcomes that displays a net positive harm/benefit ratio. -
Overtreatment and Informed Consent: a Fraud-Based Solution to Unwanted and Unnecessary Care
Florida State University Law Review Volume 43 Issue 3 Spring 2016 Article 3 Spring 2016 Overtreatment and Informed Consent: A Fraud-Based Solution to Unwanted and Unnecessary Care Isaac D. Buck University of Tennessee College of Law Follow this and additional works at: https://ir.law.fsu.edu/lr Part of the Health Law and Policy Commons, Medical Jurisprudence Commons, and the Torts Commons Recommended Citation Isaac D. Buck, Overtreatment and Informed Consent: A Fraud-Based Solution to Unwanted and Unnecessary Care, 43 Fla. St. U. L. Rev. 901 (2017) . https://ir.law.fsu.edu/lr/vol43/iss3/3 This Article is brought to you for free and open access by Scholarship Repository. It has been accepted for inclusion in Florida State University Law Review by an authorized editor of Scholarship Repository. For more information, please contact [email protected]. OVERTREATMENT AND INFORMED CONSENT: A FRAUD-BASED SOLUTION TO UNWANTED AND UNNECESSARY CARE ISAAC D. BUCK† ABSTRACT According to multiple accounts, the administration of American health care results in as much as $800 billion in wasted spending due largely to the provision of overly expensive, inefficient, and unnecessary services. Beyond inflicting fiscal pain on the nation’s pocketbook, this waste has no clinical benefit—and often results in unnecessary hospital stays, cascading follow-up procedures, and time-wasting inconvenience for American patients. But aside from the mere annoyance of unnecessary care, the administration of overtreatment—that is, unnec- essary care in and of itself—causes harm to the patient. Excessive care is deficient care. Un- necessary care risks potential medical error and infection, and often subjects the patient to excessive recovery and rehabilitation. -
Unnecessary Health Care
Jubiläum 1989–2019 UNNECESSARY HEALTH CARE Thomas Baumann Overutilization, overuse, 2. Children with isolated linear skull fractures and normal Glasgow coma scale scores do not require or overtreatment and quaternary hospitalization for observation or re-imaging. prevention 3. Using antidepressants in adolescents is likely in- The black hole in pediatrics effective and possibly harmful. 4. Most (70% to 80%) of hospitalized children with Introduction community-acquired pneumonia have a virus or Thomas Baumann In our daily business, unnecessary healthcare is not mycoplasma as causative pathogen, not bacteria. obvious. But already in 2010 the US Institute of Me- dicine (IOM) called attention to the problem, sugge- 5. Oral antibiotics are as effective as, and much sa- sting that «unnecessary services» are the largest con- fer than, peripherally inserted central catheters tributor to excessive healthcare costs, accounting for for the treatment of acute osteomyelitis. approximately $ 210 billion of an estimated $ 750 bil- lion in excess spending each year1). In previous stu- 6. The exchange transfusion threshold for infants dies of different medical subspecialties, 30% of inpa- with hyperbilirubinemia is likely too low and should tient antimicrobial therapy2), 26% of advanced ima- be raised because the risk of cerebral palsy and ging3), and 12% of acute percutaneous coronary kernicterus is extremely low. interventions were found to be unnecessary or in- appropriate4). The US academy of sciences estimated 7. Nebulized hypertonic saline is not superior to nor- in 2005 that «between $ 30 and $ 40 of every dollar mal nebulized saline for management of inpatient spent on healthcare is spent on costs poor quality he- bronchiolitis. -
Overdiagnosis and Overtreatment Over Time
Diagnosis 2015; 2(2): 105–109 Opinion Paper Open Access Stephen A. Martin*, Scott H. Podolsky and Jeremy A. Greene Overdiagnosis and overtreatment over time Abstract: Overdiagnosis and overtreatment are often Introduction thought of as relatively recent phenomena, influenced by a contemporary combination of technology, speciali- In recent years, an increasing number of clinicians, jour- zation, payment models, marketing, and supply-related nalists, health service researchers, and policy-makers demand. Yet a quick glance at the historical record reveals have drawn attention to the problems of overdiagnosis that physicians and medical manufacturers have been and the overtreatment that it so often engenders [1, 2]. accused of iatrogenic excess for centuries, if not millen- Proliferating screening modalities, diagnostic tests, and nia. Medicine has long had therapeutic solutions that imaging platforms, often accompanied by strong market- search for ever-increasing diagnostic problems. Whether ing and weak oversight, present otherwise healthy people the intervention at hand has been leeches and lancets, with diagnoses that may well lead to more harm than calomel and cathartics, aspirins and amphetamines, or good. Using a variety of descriptions – disease-mongering statins and SSRIs, medical history is replete with skeptical [3], diagnostic creep [4], or medicalization [5] – critics critiques of diagnostic and therapeutic enthusiasm. The have pointed to the need to address the issue of overdi- opportunity cost of this profusion shapes the other side agnosis before we enact irreparable cost and harm to our of the coin: chronic persistence of underdiagnosis and bodies, pocketbooks, and health care systems. undertreatment. Drawing from key controversies of the Even though this problem has become particularly 19th and 20th centuries, we chart the enduring challenges acute in the early 21st century, the critique of overdiagno- of inter-related diagnostic and therapeutic excess.